Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

85 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Intracerebral transplantation of MRI-trackable autologous bone marrow stromal cells for patients with subacute ischemic stroke.
Kawabori M, Kuroda S, Shichinohe H, Kahata K, Shiratori S, Ikeda S, Harada T, Hirata K, Tha KK, Aragaki M, Terasaka S, Ito YM, Nishimoto N, Ohnishi S, Yabe I, Kudo K, Houkin K, Fujimura M. Kawabori M, et al. Among authors: kahata k. Med. 2024 May 10;5(5):432-444.e4. doi: 10.1016/j.medj.2024.02.009. Epub 2024 Mar 27. Med. 2024. PMID: 38547868 Free article. Clinical Trial.
Protocol for treating lumbar spinal canal stenosis with a combination of ultrapurified, allogenic bone marrow-derived mesenchymal stem cells and in situ-forming gel: a multicentre, prospective, double-blind randomised controlled trial.
Sudo H, Miyakoshi T, Watanabe Y, Ito YM, Kahata K, Tha KK, Yokota N, Kato H, Terada T, Iwasaki N, Arato T, Sato N, Isoe T. Sudo H, et al. Among authors: kahata k. BMJ Open. 2023 Feb 2;13(2):e065476. doi: 10.1136/bmjopen-2022-065476. BMJ Open. 2023. PMID: 36731929 Free PMC article.
The association between the incidence of intestinal graft-vs-host disease and antibiotic use after allogeneic hematopoietic stem cell transplantation.
Hidaka D, Hayase E, Shiratori S, Hasegawa Y, Ishio T, Tateno T, Okada K, Goto H, Sugita J, Onozawa M, Nakagawa M, Kahata K, Endo T, Hashimoto D, Teshima T. Hidaka D, et al. Among authors: kahata k. Clin Transplant. 2018 Sep;32(9):e13361. doi: 10.1111/ctr.13361. Epub 2018 Aug 13. Clin Transplant. 2018. PMID: 30054935
Disseminated toxoplasmosis after hematopoietic stem cell transplantation showing unusual magnetic resonance images.
Tateno T, Onozawa M, Hashiguchi J, Ishio T, Yuzawa S, Matsuoka S, Kosugi-Kanaya M, Okada K, Shiratori S, Goto H, Kimura T, Sugita J, Nakagawa M, Hashimoto D, Kahata K, Fujimoto K, Endo T, Kondo T, Tanaka S, Hashino S, Teshima T. Tateno T, et al. Among authors: kahata k. Transpl Infect Dis. 2017 Aug;19(4). doi: 10.1111/tid.12720. Epub 2017 Jun 20. Transpl Infect Dis. 2017. PMID: 28474756
Increased risk of bacterial infection after engraftment in patients treated with allogeneic bone marrow transplantation following reduced-intensity conditioning regimen.
Shigematsu A, Yamamoto S, Sugita J, Kondo T, Onozawa M, Kahata K, Endo T, Shiratori S, Ota S, Yamaguchi K, Wakasa K, Takahata M, Goto H, Ito S, Takemura R, Tanaka J, Hashino S, Nishio M, Koike T, Asaka M, Imamura M. Shigematsu A, et al. Among authors: kahata k. Transpl Infect Dis. 2010 Oct;12(5):412-20. doi: 10.1111/j.1399-3062.2010.00560.x. Epub 2010 Aug 24. Transpl Infect Dis. 2010. PMID: 20738830
T-cell depletion effects of low-dose antithymocyte globulin for GVHD prophylaxis in HLA-matched allogeneic peripheral blood stem cell transplantation.
Shiratori S, Kosugi-Kanaya M, Hayase E, Okada K, Goto H, Sugita J, Onozawa M, Nakagawa M, Kahata K, Hashimoto D, Endo T, Kondo T, Teshima T. Shiratori S, et al. Among authors: kahata k. Transpl Immunol. 2018 Feb;46:21-22. doi: 10.1016/j.trim.2017.11.001. Epub 2017 Nov 8. Transpl Immunol. 2018. PMID: 29128394 No abstract available.
Hematogones Predict Better Outcome in Allogeneic Hematopoietic Stem Cell Transplantation Irrespective of Graft Sources.
Ishio T, Sugita J, Tateno T, Hidaka D, Hayase E, Shiratori S, Okada K, Goto H, Onozawa M, Nakagawa M, Hashimoto D, Kahata K, Fujimoto K, Endo T, Kondo T, Teshima T. Ishio T, et al. Among authors: kahata k. Biol Blood Marrow Transplant. 2018 Oct;24(10):1990-1996. doi: 10.1016/j.bbmt.2018.06.011. Epub 2018 Jun 15. Biol Blood Marrow Transplant. 2018. PMID: 29909151 Free article. Clinical Trial.
Reduced dose of MTX for GVHD prophylaxis promotes engraftment and decreases non-relapse mortality in umbilical cord blood transplantation.
Shiratori S, Ohigashi H, Takahashi S, Ara T, Goto H, Nakagawa M, Sugita J, Onozawa M, Kahata K, Endo T, Hashimoto D, Teshima T; North Japan Hematology Study Group (NJHSG). Shiratori S, et al. Among authors: kahata k. Ann Hematol. 2020 Mar;99(3):591-598. doi: 10.1007/s00277-020-03937-3. Epub 2020 Feb 1. Ann Hematol. 2020. PMID: 32006152 Clinical Trial.
Feasibility and efficacy of low-dose pegfilgrastim for CD34+ cell mobilization in lymphoma.
Goto H, Hidaka D, Yamamoto S, Hayasaka K, Michimata R, Kagawa I, Sunagoya K, Iijima H, Hayase E, Shiratori S, Okada K, Sugita J, Onozawa M, Hashimoto D, Kahata K, Fujimoto K, Endo T, Shimizu C, Teshima T; North Japan Hematology Study Group (NJHSG). Goto H, et al. Among authors: kahata k. J Clin Apher. 2020 Sep;35(5):413-419. doi: 10.1002/jca.21816. Epub 2020 Jul 29. J Clin Apher. 2020. PMID: 33043486
85 results